These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14064391)

  • 1. [PREVENTION OF HYPERACTIVE ERYTHROPOIESIS AS A THERAPEUTIC CRITERION IN THALASSEMIA AND OTHER CORPUSCULAR ANEMIAS. PRELIMINARY NOTE].
    REWALD EF
    Prensa Med Argent; 1963 Feb; 50():499-500. PubMed ID: 14064391
    [No Abstract]   [Full Text] [Related]  

  • 2. SUBSTITUTIVE-INHIBITORY THERAPY IN CONSTITUTIONAL NON-SPHEROCYTIC ERYTHROCYTIC DISEASE.
    REWALD E
    Acta Haematol; 1964 May; 31():303-9. PubMed ID: 14172699
    [No Abstract]   [Full Text] [Related]  

  • 3. [PRELIMINARY NOTE ON THE THERAPEUTIC USE OF DESFERRIOXAMINE IN COOLEY'S DISEASE].
    ROMANO C; MASSIMO L; TORTOROLO G
    Minerva Pediatr; 1964 Jun; 16():711-3. PubMed ID: 14180248
    [No Abstract]   [Full Text] [Related]  

  • 4. [A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
    SCURO LA; BROCCIA G; DOBRILLA G; TAGLIAMONTE A
    Policlinico Prat; 1964 Jul; 71():1101-13. PubMed ID: 14174378
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
    CARLOS AG; SOARES AD
    J Med (Oporto); 1964 Apr; 53():1021-32. PubMed ID: 14145895
    [No Abstract]   [Full Text] [Related]  

  • 6. CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
    HILDNER FJ; MONTO RW; REBUCK JW
    Henry Ford Hosp Med Bull; 1964 Mar; 12():5-13. PubMed ID: 14129631
    [No Abstract]   [Full Text] [Related]  

  • 7. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
    WOEHLER F
    Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
    [No Abstract]   [Full Text] [Related]  

  • 8. [EFFECT OF DESFERRIOXAMINE ON ERYTHROPOIESIS].
    KELLER HM
    Schweiz Med Wochenschr; 1963 Oct; 93():1511-2. PubMed ID: 14093399
    [No Abstract]   [Full Text] [Related]  

  • 9. ENZYMATIC DEFECTS OF HEME SYNTHESIS IN THALASSEMIA.
    STEINER M; BALDINI M; DAMESHEK W
    Ann N Y Acad Sci; 1964 Oct; 119():548-56. PubMed ID: 14219433
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE BEHAVIOR OF THE LIFE-SPAN OF THE ERYTHROCYTES AND SOME INDEXES OF ERYTHROPOIESIS MEASURED WITH CR-51 IN SUBJECTS WITH THALASSEMIA MAJOR AND THALASSO-DREPANOCYTIC ANEMIA, BEFORE AND AFTER SPLENECTOMY].
    PRIOLISI A; GIUFFRE L
    Pediatria (Napoli); 1964 Apr; 72():266-82. PubMed ID: 14151462
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT OF HEMOSIDEROSIS SECONDARY TO MULTIPLE TRANSFUSIONS, WITH SPECIAL REFERENCE TO COOLEY'S HEMOLYTIC ANEMIA].
    RITTER M
    Hospital (Rio J); 1964 Oct; 66():861-6. PubMed ID: 14226293
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of erythropoiesis in hypochromic anemias during the treatment with blood and its components.
    TSEL'TNER NG
    Klin Med (Mosk); 1952 Nov; 30(11):87. PubMed ID: 13023915
    [No Abstract]   [Full Text] [Related]  

  • 13. [IRON EXCHANGE IN VARIOUS ANEMIC-HEMOLYTIC CONSTITUTIONAL BLOOD DISEASE: THALASSEMIA MAJOR, ELLIPTOCYTIC ANEMIA].
    SCHETTINI F
    Pediatria (Napoli); 1964; 72():29-38. PubMed ID: 14163249
    [No Abstract]   [Full Text] [Related]  

  • 14. [CONGENITAL HYPOPLASTIC ANEMIA. REVIEW AND REPORT ON A CASE TREATED WITH DESFERRIOXAMINE B].
    KARSTOFT H
    Ugeskr Laeger; 1964 Jul; 126():929-33. PubMed ID: 14176761
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical removal of iron.
    Propper R; Nathan D
    Annu Rev Med; 1982; 33():509-19. PubMed ID: 6282184
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ
    Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
    Vadász G
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2077-80. PubMed ID: 4216814
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrokinetics and splenic function in thalassemic syndromes].
    Torlontano G; Tata A; Proietti M
    Recenti Prog Med; 1971 Mar; 50(3):246-71. PubMed ID: 5109833
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: Lack of association with markers of erythropoiesis, iron metabolism and renal function.
    Patsaoura A; Tatsi E; Margeli A; Kanavaki I; Delaporta P; Kyriakopoulou D; Kouraklis-Symeonidis A; Kattamis A; Papassotiriou I
    Clin Biochem; 2014 Aug; 47(12):1060-4. PubMed ID: 24721683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic anaemia with features of both thalassaemia and congenital dyserythropoietic anaemia.
    Weatherall DJ; Clegg JB; Knox-Macaulay HH; Bunch C; Hopkins CR; Temperley IJ
    Br J Haematol; 1973 Aug; 25(2):286. PubMed ID: 4726922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.